SCHEMBL1086236

SCHEMBL1086236

O=C(O[PH](=O)O)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.56
F2 P00734 1/20 0.56
TSHR P16473 5/20 0.52
ALDH1A1 P00352 4/20 0.50
KMT2A Q03164 4/20 0.50
MAPT P10636 3/20 0.50
POLB P06746 1/20 0.50
TDP1 Q9NUW8 4/20 0.47
TP53 P04637 1/20 0.47
MAPK1 P28482 1/20 0.45
HIF1A Q16665 1/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A3 Q01959 1/20 0.45
CES2 O00748 2/20 0.44
CES1 P23141 2/20 0.44
DAO P14920 1/20 0.44
NAPRT Q6XQN6 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PLA2G7 Q13093 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butane SCHEMBL1296448 0.90 LMNA (0.55) LMNAF2TSHRALDH1A1KMT2A
SCHEMBL27565511 0.84 TSHR (0.52) TSHRALDH1A1MAPTTP53CES2
SCHEMBL1086234 0.84 LMNA (0.58) LMNAF2TSHRALDH1A1KMT2A
SCHEMBL27912474 0.80 LMNA (0.67) LMNAF2TSHRALDH1A1KMT2A
SCHEMBL21840795 0.78 LMNA (0.52) LMNAF2TSHRALDH1A1KMT2A
SCHEMBL30946950 0.77 TSHR (0.57) LMNAF2TSHRALDH1A1KMT2A
SCHEMBL27679738 0.77 ALDH1A1 (0.56) LMNATSHRALDH1A1KMT2AMAPT
SCHEMBL7231215 0.76 LMNA (0.38) LMNAF2TSHRALDH1A1KMT2A
SCHEMBL30617938 0.75 TSHR (0.55) LMNAF2TSHRALDH1A1KMT2A
SCHEMBL2911372 0.75 TSHR (0.55) LMNAF2TSHRALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113340835-B Method for detecting quality of photoinitiator and application thereof 湖南松井新材料股份有限公司 2023-05-02 CN claimed
CN-113340835-A Method for detecting quality of photoinitiator and application thereof 湖南松井新材料股份有限公司 2021-09-03 CN claimed
CN-105339445-B Industrial deinking of ink compositions 西康制造有限公司 2019-07-05 CN claimed
CN-113340835-B Method for detecting quality of photoinitiator and application thereof 湖南松井新材料股份有限公司 2023-05-02 CN disclosed
CN-106165175-B High molecular electrolyte composition and polyelectrolyte membrane, film electrode composite element and the polymer electrolyte fuel cell for using it 东丽株式会社 2019-11-08 CN disclosed
CN-106117394-B A kind of phosphonic acid ester photoinitiator containing fluorocarbon chain and preparation method thereof 中山大学 2018-06-01 CN disclosed
CN-106165175-A High molecular electrolyte composition and use its polyelectrolyte membrane, film electrode composite element and polymer electrolyte fuel cell 东丽株式会社 2016-11-23 CN disclosed
CN-106117394-A A kind of phosphonic acid ester light trigger containing fluorocarbon chain and preparation method thereof 中山大学 2016-11-16 CN disclosed
CN-106065087-A Flame retardant flame retardant composition and molded body and manufacturing method thereof 双键化工(上海)有限公司 2016-11-02 CN disclosed
US-8637158-B2 Polymerizable composition for coating metals HENKEL AG & CO. KGAA (DE) 2014-01-28 US disclosed
US-8153615-B2 Synthesis of glycerolipid carbamates and dicarbamates and their use as an antitumor compounds THE UNIVERSITY OF MANITOBA (CA) 2012-04-10 US disclosed
US-20100081001-A1 POLYMERIZABLE COMPOSITION FOR COATING METALS HENKEL AG & CO. KGAA (DE) 2010-04-01 US disclosed
US-20090042811-A1 Synthesis of Glycerolipid Carbamates and Dicarbamates and Their Use as an Antitumor Compounds THE UNIVERSITY OF MANITOBA (CA) 2009-02-12 US disclosed
CN-101074242-A Cells accumulation for sphosphonate analogs of HIV protease inhibitor compound and the same compound GILEAD SCIENCES INC (US) 2007-11-21 CN disclosed
CN-1313472-C Cellular Accumulation of Phosphonate Analogs of HIV Protease Inhibitor Compounds and Such Compounds GILEAD SCIENCES INC (US) 2007-05-02 CN disclosed
WO-2006130994-A1 SYNTHESIS OF GLYCEROLIPID CARBAMATES AND DICARBAMATES AND THEIR USE AS ANTITUMOR COMPOUNDS THE UNIVERSITY OF MANITOBA (CA) 2006-12-14 WO disclosed
CN-1649885-A Cellular Accumulation of Phosphonate Analogs of HIV Protease Inhibitor Compounds and Such Compounds GILEAD SCIENCES INC (US) 2005-08-03 CN disclosed
US-4517010-A 2-Nitro-5(substituted-phenoxy) benzoyl derivatives as herbicides RHONE-POULENC INC. (US) 1985-05-14 US disclosed
EP-0034883-A1 2-Nitro-5-(substituted-phenoxy) benzoyl derivatives as herbicides RHONE-POULENC INC. (US) 1981-09-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042811-A1 Synthesis of Glycerolipid Carbamates and Dicarbamates and Their Use as an Antitumor Compounds PHOSPHO1, SGMS1, UGCG LMNA 410/4885F2 3199/4885TSHR 4344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.